Clinical trial
A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of…
NCT04050865 · Ocular Therapeutix, Inc., Industry · Completed
Key facts
| NCT number | NCT04050865 |
|---|---|
| Title | A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis |
| Official title | CLN-0052, A Multi-Center, Randomized, Double-Masked, Vehicle Controlled Phase 3 Study Evaluation the Efficacy and Safety of OTX-DP for the Treatment of Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model (Ora-CAC®) |
| Lead sponsor | Ocular Therapeutix, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Allergic Conjunctivitis |
| Intervention type | Device, Drug |
| Interventions | Dexamethasone, 0.4mg, Placebo plug with no drug |
| Enrollment | 96 |
| Start date | Aug 5, 2019 |
| Primary completion | Feb 28, 2020 |
| Completion | Feb 28, 2020 |
| First posted | Aug 8, 2019 |
| Last update posted | Oct 7, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: